← FDA DRUG APPROVALS

FDA ANDA · ANDA073193

DESOXIMETASONE

Sponsor: TARO

APPLICATION
ANDA073193
TYPE
ANDA
ORIGINAL APPROVAL
1990-11-29
LATEST ACTION
2012-01-03
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

TOPICORTPrescription
DESOXIMETASONE 0.25% · CREAM · TOPICAL

Approval history

2012-01-03Labeling · Supplement 33 — Letter ↗AP
2008-02-29Labeling · Supplement 27AP
2004-11-23Labeling · Supplement 22AP
2004-02-19Labeling · Supplement 21AP
2003-12-19Labeling · Supplement 20AP
2001-06-20Manufacturing (CMC) · Supplement 15AP
2000-05-03Manufacturing (CMC) · Supplement 14AP
1999-04-09Manufacturing (CMC) · Supplement 13AP
1996-09-17Manufacturing (CMC) · Supplement 6AP
1996-05-15Manufacturing (CMC) · Supplement 5AP
1990-11-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →